C4 α Antibodies

Santa Cruz Biotechnology offers a broad range of C4 α monoclonal antibodies for research focused on understanding complement component C4 in immune responses. C4 α monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C4 plays a crucial role in the complement system by facilitating the opsonization of pathogens and activating immune responses. Through both classical and lectin pathways of complement activation, C4 contributes to inflammation and helps clear immune complexes. Understanding C4 function is essential for discovering mechanisms of immune regulation and potential therapeutic targets in autoimmune diseases. Researchers investigating complement pathways can utilize C4 α monoclonal antibodies to examine protein expression patterns across different tissue types. Advanced imaging techniques combined with C4 α monoclonal antibodies enable detailed visualization of protein localization and interactions. Comprehensive studies of C4 expression and regulation provide insights into normal immune function and disease states. Santa Cruz Biotechnology monoclonal antibodies for C4 α support cutting-edge research that advances our understanding of immune system complexity.